BNP Paribas Exane Upgrades Adient (NYSE:ADNT) to “Outperform”

Adient (NYSE:ADNTGet Free Report) was upgraded by stock analysts at BNP Paribas Exane from a “neutral” rating to an “outperform” rating in a report released on Thursday, Marketbeat Ratings reports. The firm presently has a $26.00 target price on the stock. BNP Paribas Exane’s price objective suggests a potential upside of 20.48% from the company’s previous close.

A number of other analysts have also recently issued reports on the company. Barclays increased their target price on Adient from $26.00 to $29.00 and gave the stock an “equal weight” rating in a research note on Monday, May 11th. Stifel Nicolaus reduced their price target on shares of Adient from $28.00 to $26.00 and set a “buy” rating for the company in a report on Monday, July 20th. UBS Group increased their price objective on shares of Adient from $33.00 to $34.00 and gave the stock a “buy” rating in a research report on Thursday, July 9th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Adient from $31.00 to $29.00 and set a “buy” rating on the stock in a report on Monday, July 6th. Finally, Weiss Ratings raised shares of Adient from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 13th. Six investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $27.90.

Check Out Our Latest Stock Analysis on ADNT

Adient Stock Down 0.2%

NYSE:ADNT opened at $21.58 on Thursday. Adient has a 1 year low of $17.68 and a 1 year high of $27.32. The stock has a 50-day moving average price of $20.84 and a two-hundred day moving average price of $21.62. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of 30.39, a PEG ratio of 0.42 and a beta of 1.53. The company has a current ratio of 1.10, a quick ratio of 0.91 and a debt-to-equity ratio of 1.18.

Adient (NYSE:ADNTGet Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.44 by $0.08. Adient had a return on equity of 7.28% and a net margin of 0.39%.The company had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.62 billion. During the same quarter last year, the firm posted $0.69 earnings per share. Adient’s revenue was up 7.0% compared to the same quarter last year. As a group, equities analysts expect that Adient will post 2.13 earnings per share for the current year.

Insider Activity

In related news, EVP Heather M. Tiltmann sold 22,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $22.71, for a total transaction of $499,620.00. Following the sale, the executive vice president owned 110,886 shares in the company, valued at approximately $2,518,221.06. This represents a 16.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.94% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its stake in shares of Adient by 4.7% during the 4th quarter. Vanguard Group Inc. now owns 4,684,882 shares of the company’s stock worth $89,809,000 after purchasing an additional 208,938 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Adient by 5.1% in the first quarter. Dimensional Fund Advisors LP now owns 4,384,904 shares of the company’s stock valued at $88,614,000 after buying an additional 211,843 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its stake in shares of Adient by 17.2% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,293,353 shares of the company’s stock valued at $46,349,000 after buying an additional 336,306 shares in the last quarter. UBS Group AG increased its holdings in Adient by 12.9% during the fourth quarter. UBS Group AG now owns 1,848,690 shares of the company’s stock worth $35,439,000 after buying an additional 210,758 shares during the last quarter. Finally, Invesco Ltd. increased its holdings in Adient by 38.6% during the fourth quarter. Invesco Ltd. now owns 1,599,937 shares of the company’s stock worth $30,671,000 after buying an additional 445,343 shares during the last quarter. Institutional investors and hedge funds own 92.44% of the company’s stock.

Adient Company Profile

(Get Free Report)

Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.

Further Reading

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.